Newborn Dried Blood Spot Folate in Relation to Maternal Self-reported Folic Acid Intake, Autism Spectrum Disorder, and Developmental Delay-Reference-Cited by-同舟云学术

Newborn Dried Blood Spot Folate in Relation to Maternal Self-reported Folic Acid Intake, Autism Spectrum Disorder, and Developmental Delay

Published:2024-06-24 Issue:4 Volume:35 Page:527-541
ISSN:1044-3983
Container-title:Epidemiology
language:en
Short-container-title:

Author:

Schmidt Rebecca J.¹²^ORCID,Goodrich Amanda J.¹,Delwiche Lora¹,Hansen Robin L.²³,Simpson Claire L.⁴,Tancredi Daniel³,Volk Heather E.⁵

Affiliation:

1. Department of Public Health Sciences, School of Medicine, University of California Davis, Sacramento, CA

2. Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, Sacramento, CA

3. Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, CA

4. Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN

5. Departments of Mental Health and Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.

Abstract

Background: Maternal folic acid intake has been associated with decreased risk for neurodevelopmental disorders including autism spectrum disorder (ASD). Genetic differences in folate metabolism could explain some inconsistencies. To our knowledge, newborn folate concentrations remain unexamined. Methods: We measured folate in archived newborn dried blood spots of children from the CHARGE (Childhood Autism Risks from Genetics and the Environment) case–control study who were clinically confirmed at 24–60 months to have ASD (n = 380), developmental delay (n = 128), or typical development (n = 247). We quantified monthly folic acid intake from maternally-reported supplements and cereals consumed during pregnancy and 3 months prior. We assessed associations of newborn folate with maternal folic acid intake and with ASD or developmental delay using regression. We stratified estimates across maternal and child MTHFR genotypes. Results: Among typically developing children, maternal folic acid intake in prepregnancy and each pregnancy month and prepregnancy prenatal vitamin intake were positively associated with newborn folate. Among children with ASD, prenatal vitamin intake in pregnancy months 2–9 was positively associated with newborn folate. Among children with developmental delay, maternal folic acid and prenatal vitamins during the first pregnancy month were positively associated with neonatal folate. Associations differed by MTHFR genotype. Overall, neonatal folate was not associated with ASD or developmental delay, though we observed associations with ASD in children with the MTHFR 677 TT genotype (odds ratio: 1.76, 95% CI = 1.19, 2.62; P for interaction = 0.08). Conclusion: Maternal prenatal folic acid intake was associated with neonatal folate at different times across neurodevelopmental groups. Neonatal folate was not associated with reduced ASD risk. MTHFR genotypes modulated these relationships.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference58 articles.

1. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid.;Fed Regist,8797

2. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.;Lancet,1991

3. Maternal folic acid supplement use in early pregnancy and child behavioural problems: the generation R study.;Roza;Br J Nutr,2010

4. Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort.;Julvez;Paediatr Perinat Epidemiol,2009

5. Lower maternal folate status in early pregnancy is associated with childhood hyperactivity and peer problems in offspring.;Schlotz;J Child Psychol Psychiatry,2010